Chemokine (C-C motif) receptor 5 entry inhibitors: new class of drugs for acquired immune deficiency syndrome.
Jacovina
Andrew
A
Department of Genetics and Genomic Science, Mount Sinai School of Medicine, New York, NY, USA.
New
Maria
M
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D044966:Anti-Retroviral Agents / Q000627:therapeutic use; D065100:CCR5 Receptor Antagonists; D015496:CD4-Positive T-Lymphocytes / Q000187:drug effects*; D015497:HIV-1 / Q000187:drug effects; D006801:Humans; D019713:Receptors, CCR5 / Q000187:drug effects; D014481:United States; D014486:United States Food and Drug Administration
D019380:Anti-HIV Agents; D044966:Anti-Retroviral Agents; D065100:CCR5 Receptor Antagonists; D019713:Receptors, CCR5